CN Stock MarketDetailed Quotes

688658 Youcare Pharmaceutical Group

Watchlist
  • 20.35
  • +3.07+17.77%
Market Closed Sep 30 15:00 CST
9.16BMarket Cap95.09P/E (TTM)

Youcare Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
-3.79%1.51B
-1.88%1.73B
-10.67%1.48B
-17.72%1.42B
-17.60%1.57B
-19.45%1.77B
-31.98%1.66B
-22.64%1.73B
-9.42%1.9B
-2.21%2.19B
Transactional financial assets
----
----
----
----
----
----
----
25.00%100M
-44.44%100M
----
Notes receivable and accounts receivable
-19.53%873.94M
-23.89%932.81M
-22.44%995.7M
-34.85%845.07M
26.20%1.09B
56.61%1.23B
48.20%1.28B
114.51%1.3B
56.33%860.53M
70.16%782.55M
-Notes receivable
95.34%118.78M
43.84%108.88M
82.24%101.94M
68.68%81.39M
24.90%60.81M
41.79%75.7M
13.05%55.94M
45.65%48.25M
65.23%48.68M
37.41%53.39M
-Accounts receivable
-26.34%755.16M
-28.35%823.93M
-27.21%893.77M
-38.85%763.69M
26.28%1.03B
57.70%1.15B
50.32%1.23B
118.50%1.25B
55.83%811.85M
73.18%729.16M
Other receivables (including interest and dividends)
-36.89%10.78M
-36.27%15.19M
-4.75%10.86M
209.39%68.2M
16.40%17.08M
52.16%23.83M
24.34%11.4M
44.37%22.04M
75.56%14.67M
77.26%15.66M
-Accrued interest receivable
-6.67%439.88K
----
----
-28.19%987.56K
-10.88%471.33K
----
----
-68.94%1.38M
-70.35%528.85K
----
-Other receivable
-37.75%10.34M
----
-4.75%10.86M
----
17.42%16.61M
----
24.34%11.4M
----
115.15%14.14M
----
Contractual assets
-54.34%450.44K
-78.41%321.51K
-76.41%337.19K
-70.93%956.35K
-68.12%986.59K
-72.29%1.49M
-72.73%1.43M
-52.96%3.29M
-55.73%3.09M
-37.85%5.37M
Advance payment
-25.88%37.76M
-6.37%49.7M
22.20%72.97M
3.96%67.15M
6.97%50.94M
33.24%53.09M
100.86%59.71M
183.08%64.59M
92.99%47.62M
72.96%39.84M
Inventories
-0.00%764.14M
-10.21%745.06M
-1.44%727.69M
0.84%752.82M
-7.23%764.16M
10.89%829.78M
16.77%738.34M
35.17%746.55M
51.14%823.73M
17.54%748.32M
Receivable financing
-5.93%74.95M
-6.94%107.67M
21.15%97.58M
13.13%86.57M
134.24%79.68M
1,057.67%115.7M
45.15%80.55M
241.24%76.52M
23.28%34.02M
-39.92%9.99M
Other current assets
58.32%47.16M
-42.35%42.72M
-43.16%39.31M
69.18%50.88M
-14.10%29.79M
105.11%74.1M
119.96%69.15M
31.41%30.08M
50.94%34.68M
26.58%36.13M
Total current assets
-7.76%3.32B
-11.33%3.63B
-12.22%3.42B
-19.05%3.29B
-5.87%3.59B
6.77%4.09B
-4.04%3.9B
14.22%4.07B
10.24%3.82B
6.42%3.83B
Non Current assets
Other equity investment
0.00%500K
--500K
--500K
--500K
--500K
----
----
----
----
----
Other non-current financial assets
58.50%25.25M
1.69%15.25M
--15.25M
--15.93M
--15.93M
--15M
----
----
----
----
Fixed assets
27.75%1.47B
----
24.65%1.45B
----
-2.35%1.15B
----
-2.87%1.16B
----
0.14%1.18B
----
Constru in process
-17.68%475.95M
----
2.74%470.99M
----
219.46%578.17M
----
511.70%458.45M
----
84.61%180.98M
----
Intangible assets
-0.57%172.15M
-2.48%172.3M
-0.20%174.32M
-3.58%172.91M
-3.53%173.14M
-4.06%176.69M
-3.57%174.68M
34.16%179.33M
32.39%179.49M
34.03%184.17M
Development expenditure
21.55%278.09M
31.86%268.95M
34.24%260.53M
61.26%254.68M
53.70%228.78M
63.94%203.97M
101.82%194.08M
19.02%157.93M
18.37%148.85M
4.45%124.42M
Long deferred expense
-13.08%9.83M
586.89%9.23M
1,129.81%10.11M
55.25%8.48M
163.45%11.3M
-71.53%1.34M
-51.85%822.43K
167.04%5.46M
55.34%4.29M
34.28%4.72M
Deferred tax assets
8.14%17.27M
3.24%19.03M
14.46%20.39M
-37.30%18.86M
-40.44%15.97M
-17.07%18.43M
44.33%17.82M
185.52%30.08M
178.52%26.81M
159.94%22.23M
Usufruct assets
-24.35%32.06M
-22.95%34.64M
-21.71%37.22M
-24.80%39.8M
-23.83%42.38M
-22.95%44.96M
70.94%47.54M
273.03%52.93M
277.07%55.64M
280.81%58.36M
Other non current assets
-35.62%55.97M
-26.44%36.21M
-7.80%45.5M
-55.09%69.2M
-26.08%86.94M
-64.31%49.22M
-27.23%49.34M
268.12%154.09M
238.68%117.62M
401.66%137.89M
Total non current assets
10.15%2.54B
13.65%2.48B
17.99%2.49B
22.99%2.42B
21.73%2.31B
19.53%2.18B
26.88%2.11B
21.71%1.97B
17.66%1.9B
12.95%1.83B
Total assets
-0.76%5.86B
-2.63%6.11B
-1.62%5.91B
-5.35%5.71B
3.29%5.9B
10.90%6.27B
4.92%6.01B
16.56%6.04B
12.60%5.71B
8.45%5.66B
Liabilities
Current liabilities
Short term loan
-17.79%310.77M
62.86%372.68M
54.05%351.77M
238.41%372.6M
--378M
--228.84M
2,434.19%228.35M
1,122.03%110.1M
----
----
Notes payable and accounts payable
-20.31%630.79M
-21.79%688.7M
-7.26%720.95M
-12.18%693.11M
3.79%791.56M
8.99%880.59M
-2.83%777.4M
16.32%789.28M
15.97%762.66M
13.38%807.96M
-Notes payable
-36.65%213.75M
-24.97%231.24M
-23.29%215.35M
-24.35%323.32M
-17.34%337.41M
-5.42%308.19M
-2.46%280.75M
64.42%427.39M
41.86%408.21M
12.89%325.85M
-Accounts payable
-8.17%417.04M
-20.08%457.45M
1.80%505.6M
2.18%369.79M
28.13%454.16M
18.73%572.4M
-3.03%496.65M
-13.55%361.88M
-4.17%354.45M
13.71%482.11M
Contract liabilities
-41.73%23.65M
-18.21%37.49M
-48.01%29.68M
22.51%27.04M
72.34%40.59M
51.98%45.84M
92.01%57.09M
-14.50%22.07M
-34.41%23.55M
-51.38%30.16M
Advance receipts
----
----
----
----
----
----
----
----
-13.61%404.71K
----
Salaries payable
17.30%44.53M
-0.15%46.4M
10.20%51.6M
1.79%41.58M
15.60%37.96M
43.27%46.47M
-9.17%46.82M
19.92%40.85M
5.12%32.84M
-6.20%32.44M
Taxs payable
-12.86%51.74M
5.97%58.06M
16.23%72.19M
-77.73%38.57M
-35.77%59.38M
-37.36%54.79M
-52.34%62.11M
113.50%173.21M
52.70%92.44M
84.88%87.46M
Other payable (including interest and dividends)
-8.97%727.53M
-0.49%799.29M
23.76%879.45M
3.58%768.2M
47.86%799.22M
52.97%803.25M
8.82%710.63M
54.05%741.65M
-1.30%540.52M
16.25%525.09M
-Other payable
-8.97%727.53M
----
23.76%879.45M
----
47.86%799.22M
----
8.82%710.63M
----
-1.30%540.52M
----
Non current liabilities due within one year
207.45%30.76M
181.23%27.68M
180.72%27.18M
2.05%10.17M
1.62%10.01M
1.20%9.84M
103.06%9.68M
392.14%9.97M
392.17%9.85M
-53.66%9.73M
Other current liabilities
-45.05%2.86M
-17.20%4.84M
-47.68%3.81M
24.31%3.44M
76.04%5.2M
64.15%5.85M
91.39%7.27M
-5.79%2.77M
-33.55%2.96M
-55.03%3.56M
Total current liabilities
-14.10%1.82B
-1.94%2.04B
12.49%2.14B
3.43%1.95B
44.82%2.12B
38.70%2.08B
12.91%1.9B
43.70%1.89B
7.19%1.47B
3.57%1.5B
Current liabilities
Long term deferred income
48.14%104.32M
49.70%104.05M
28.66%93.05M
-9.83%70.34M
-20.07%70.42M
-27.72%69.51M
-22.82%72.32M
-12.54%78.01M
-3.99%88.1M
2.03%96.17M
Lease liabilities
-30.84%23.96M
-28.26%26.69M
-26.03%29.38M
-27.74%32.05M
-26.13%34.64M
-24.70%37.2M
67.09%39.72M
257.34%44.35M
262.72%46.89M
220.48%49.4M
Total non current liabilities
330.02%451.77M
301.98%428.93M
57.98%177M
24.54%152.39M
-22.17%105.06M
-26.69%106.71M
-4.62%112.04M
13.44%122.37M
21.68%134.99M
25.57%145.56M
Total liabilities
2.13%2.27B
12.92%2.46B
15.03%2.31B
4.71%2.11B
39.17%2.23B
32.90%2.18B
11.76%2.01B
41.41%2.01B
8.28%1.6B
5.20%1.64B
Shareholders equity
Paid-in capital
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
Capital reserve funds
0.00%2.65B
-1.68%2.65B
-1.35%2.65B
-2.34%2.65B
-1.57%2.65B
0.80%2.69B
1.37%2.68B
2.40%2.71B
1.60%2.69B
0.90%2.67B
Surplus reserve funds
18.41%162.2M
18.41%162.2M
18.39%162.2M
39.83%136.98M
39.83%136.98M
39.83%136.98M
39.86%137.01M
108.33%97.96M
108.33%97.96M
108.33%97.96M
Retained profit
-4.12%415.11M
-43.57%454.75M
-46.53%385.45M
-50.25%378.15M
-50.29%432.95M
1.49%805.86M
-1.34%720.85M
24.66%760.11M
93.89%870.9M
56.03%794.07M
Less:Treasury stock
--100.02M
--76.79M
--54.99M
--13.51M
----
----
----
----
----
----
Shareholders equity without minority interests
-2.53%3.57B
-10.97%3.64B
-10.06%3.59B
-10.45%3.6B
-10.75%3.67B
1.80%4.08B
1.67%3.99B
7.06%4.02B
14.34%4.11B
9.86%4.01B
Minority interests
6.17%9.19M
11.72%9.62M
21.06%9.8M
27.71%9.45M
34.48%8.66M
91.20%8.61M
139.65%8.09M
91.40%7.4M
39.17%6.44M
-10.95%4.5M
Total shareholder equity
-2.51%3.58B
-10.92%3.64B
-10.00%3.6B
-10.38%3.61B
-10.67%3.67B
1.90%4.09B
1.79%4B
7.14%4.02B
14.37%4.11B
9.83%4.02B
Total liabilityies and equity
-0.76%5.86B
-2.63%6.11B
-1.62%5.91B
-5.35%5.71B
3.29%5.9B
10.90%6.27B
4.92%6.01B
16.56%6.04B
12.60%5.71B
8.45%5.66B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds -3.79%1.51B-1.88%1.73B-10.67%1.48B-17.72%1.42B-17.60%1.57B-19.45%1.77B-31.98%1.66B-22.64%1.73B-9.42%1.9B-2.21%2.19B
Transactional financial assets ----------------------------25.00%100M-44.44%100M----
Notes receivable and accounts receivable -19.53%873.94M-23.89%932.81M-22.44%995.7M-34.85%845.07M26.20%1.09B56.61%1.23B48.20%1.28B114.51%1.3B56.33%860.53M70.16%782.55M
-Notes receivable 95.34%118.78M43.84%108.88M82.24%101.94M68.68%81.39M24.90%60.81M41.79%75.7M13.05%55.94M45.65%48.25M65.23%48.68M37.41%53.39M
-Accounts receivable -26.34%755.16M-28.35%823.93M-27.21%893.77M-38.85%763.69M26.28%1.03B57.70%1.15B50.32%1.23B118.50%1.25B55.83%811.85M73.18%729.16M
Other receivables (including interest and dividends) -36.89%10.78M-36.27%15.19M-4.75%10.86M209.39%68.2M16.40%17.08M52.16%23.83M24.34%11.4M44.37%22.04M75.56%14.67M77.26%15.66M
-Accrued interest receivable -6.67%439.88K---------28.19%987.56K-10.88%471.33K---------68.94%1.38M-70.35%528.85K----
-Other receivable -37.75%10.34M-----4.75%10.86M----17.42%16.61M----24.34%11.4M----115.15%14.14M----
Contractual assets -54.34%450.44K-78.41%321.51K-76.41%337.19K-70.93%956.35K-68.12%986.59K-72.29%1.49M-72.73%1.43M-52.96%3.29M-55.73%3.09M-37.85%5.37M
Advance payment -25.88%37.76M-6.37%49.7M22.20%72.97M3.96%67.15M6.97%50.94M33.24%53.09M100.86%59.71M183.08%64.59M92.99%47.62M72.96%39.84M
Inventories -0.00%764.14M-10.21%745.06M-1.44%727.69M0.84%752.82M-7.23%764.16M10.89%829.78M16.77%738.34M35.17%746.55M51.14%823.73M17.54%748.32M
Receivable financing -5.93%74.95M-6.94%107.67M21.15%97.58M13.13%86.57M134.24%79.68M1,057.67%115.7M45.15%80.55M241.24%76.52M23.28%34.02M-39.92%9.99M
Other current assets 58.32%47.16M-42.35%42.72M-43.16%39.31M69.18%50.88M-14.10%29.79M105.11%74.1M119.96%69.15M31.41%30.08M50.94%34.68M26.58%36.13M
Total current assets -7.76%3.32B-11.33%3.63B-12.22%3.42B-19.05%3.29B-5.87%3.59B6.77%4.09B-4.04%3.9B14.22%4.07B10.24%3.82B6.42%3.83B
Non Current assets
Other equity investment 0.00%500K--500K--500K--500K--500K--------------------
Other non-current financial assets 58.50%25.25M1.69%15.25M--15.25M--15.93M--15.93M--15M----------------
Fixed assets 27.75%1.47B----24.65%1.45B-----2.35%1.15B-----2.87%1.16B----0.14%1.18B----
Constru in process -17.68%475.95M----2.74%470.99M----219.46%578.17M----511.70%458.45M----84.61%180.98M----
Intangible assets -0.57%172.15M-2.48%172.3M-0.20%174.32M-3.58%172.91M-3.53%173.14M-4.06%176.69M-3.57%174.68M34.16%179.33M32.39%179.49M34.03%184.17M
Development expenditure 21.55%278.09M31.86%268.95M34.24%260.53M61.26%254.68M53.70%228.78M63.94%203.97M101.82%194.08M19.02%157.93M18.37%148.85M4.45%124.42M
Long deferred expense -13.08%9.83M586.89%9.23M1,129.81%10.11M55.25%8.48M163.45%11.3M-71.53%1.34M-51.85%822.43K167.04%5.46M55.34%4.29M34.28%4.72M
Deferred tax assets 8.14%17.27M3.24%19.03M14.46%20.39M-37.30%18.86M-40.44%15.97M-17.07%18.43M44.33%17.82M185.52%30.08M178.52%26.81M159.94%22.23M
Usufruct assets -24.35%32.06M-22.95%34.64M-21.71%37.22M-24.80%39.8M-23.83%42.38M-22.95%44.96M70.94%47.54M273.03%52.93M277.07%55.64M280.81%58.36M
Other non current assets -35.62%55.97M-26.44%36.21M-7.80%45.5M-55.09%69.2M-26.08%86.94M-64.31%49.22M-27.23%49.34M268.12%154.09M238.68%117.62M401.66%137.89M
Total non current assets 10.15%2.54B13.65%2.48B17.99%2.49B22.99%2.42B21.73%2.31B19.53%2.18B26.88%2.11B21.71%1.97B17.66%1.9B12.95%1.83B
Total assets -0.76%5.86B-2.63%6.11B-1.62%5.91B-5.35%5.71B3.29%5.9B10.90%6.27B4.92%6.01B16.56%6.04B12.60%5.71B8.45%5.66B
Liabilities
Current liabilities
Short term loan -17.79%310.77M62.86%372.68M54.05%351.77M238.41%372.6M--378M--228.84M2,434.19%228.35M1,122.03%110.1M--------
Notes payable and accounts payable -20.31%630.79M-21.79%688.7M-7.26%720.95M-12.18%693.11M3.79%791.56M8.99%880.59M-2.83%777.4M16.32%789.28M15.97%762.66M13.38%807.96M
-Notes payable -36.65%213.75M-24.97%231.24M-23.29%215.35M-24.35%323.32M-17.34%337.41M-5.42%308.19M-2.46%280.75M64.42%427.39M41.86%408.21M12.89%325.85M
-Accounts payable -8.17%417.04M-20.08%457.45M1.80%505.6M2.18%369.79M28.13%454.16M18.73%572.4M-3.03%496.65M-13.55%361.88M-4.17%354.45M13.71%482.11M
Contract liabilities -41.73%23.65M-18.21%37.49M-48.01%29.68M22.51%27.04M72.34%40.59M51.98%45.84M92.01%57.09M-14.50%22.07M-34.41%23.55M-51.38%30.16M
Advance receipts ---------------------------------13.61%404.71K----
Salaries payable 17.30%44.53M-0.15%46.4M10.20%51.6M1.79%41.58M15.60%37.96M43.27%46.47M-9.17%46.82M19.92%40.85M5.12%32.84M-6.20%32.44M
Taxs payable -12.86%51.74M5.97%58.06M16.23%72.19M-77.73%38.57M-35.77%59.38M-37.36%54.79M-52.34%62.11M113.50%173.21M52.70%92.44M84.88%87.46M
Other payable (including interest and dividends) -8.97%727.53M-0.49%799.29M23.76%879.45M3.58%768.2M47.86%799.22M52.97%803.25M8.82%710.63M54.05%741.65M-1.30%540.52M16.25%525.09M
-Other payable -8.97%727.53M----23.76%879.45M----47.86%799.22M----8.82%710.63M-----1.30%540.52M----
Non current liabilities due within one year 207.45%30.76M181.23%27.68M180.72%27.18M2.05%10.17M1.62%10.01M1.20%9.84M103.06%9.68M392.14%9.97M392.17%9.85M-53.66%9.73M
Other current liabilities -45.05%2.86M-17.20%4.84M-47.68%3.81M24.31%3.44M76.04%5.2M64.15%5.85M91.39%7.27M-5.79%2.77M-33.55%2.96M-55.03%3.56M
Total current liabilities -14.10%1.82B-1.94%2.04B12.49%2.14B3.43%1.95B44.82%2.12B38.70%2.08B12.91%1.9B43.70%1.89B7.19%1.47B3.57%1.5B
Current liabilities
Long term deferred income 48.14%104.32M49.70%104.05M28.66%93.05M-9.83%70.34M-20.07%70.42M-27.72%69.51M-22.82%72.32M-12.54%78.01M-3.99%88.1M2.03%96.17M
Lease liabilities -30.84%23.96M-28.26%26.69M-26.03%29.38M-27.74%32.05M-26.13%34.64M-24.70%37.2M67.09%39.72M257.34%44.35M262.72%46.89M220.48%49.4M
Total non current liabilities 330.02%451.77M301.98%428.93M57.98%177M24.54%152.39M-22.17%105.06M-26.69%106.71M-4.62%112.04M13.44%122.37M21.68%134.99M25.57%145.56M
Total liabilities 2.13%2.27B12.92%2.46B15.03%2.31B4.71%2.11B39.17%2.23B32.90%2.18B11.76%2.01B41.41%2.01B8.28%1.6B5.20%1.64B
Shareholders equity
Paid-in capital 0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M
Capital reserve funds 0.00%2.65B-1.68%2.65B-1.35%2.65B-2.34%2.65B-1.57%2.65B0.80%2.69B1.37%2.68B2.40%2.71B1.60%2.69B0.90%2.67B
Surplus reserve funds 18.41%162.2M18.41%162.2M18.39%162.2M39.83%136.98M39.83%136.98M39.83%136.98M39.86%137.01M108.33%97.96M108.33%97.96M108.33%97.96M
Retained profit -4.12%415.11M-43.57%454.75M-46.53%385.45M-50.25%378.15M-50.29%432.95M1.49%805.86M-1.34%720.85M24.66%760.11M93.89%870.9M56.03%794.07M
Less:Treasury stock --100.02M--76.79M--54.99M--13.51M------------------------
Shareholders equity without minority interests -2.53%3.57B-10.97%3.64B-10.06%3.59B-10.45%3.6B-10.75%3.67B1.80%4.08B1.67%3.99B7.06%4.02B14.34%4.11B9.86%4.01B
Minority interests 6.17%9.19M11.72%9.62M21.06%9.8M27.71%9.45M34.48%8.66M91.20%8.61M139.65%8.09M91.40%7.4M39.17%6.44M-10.95%4.5M
Total shareholder equity -2.51%3.58B-10.92%3.64B-10.00%3.6B-10.38%3.61B-10.67%3.67B1.90%4.09B1.79%4B7.14%4.02B14.37%4.11B9.83%4.02B
Total liabilityies and equity -0.76%5.86B-2.63%6.11B-1.62%5.91B-5.35%5.71B3.29%5.9B10.90%6.27B4.92%6.01B16.56%6.04B12.60%5.71B8.45%5.66B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data